LMRI vs RDNT
LMRI: Lumexa Imaging Holdings is a diagnostic imaging services provider leveraging a network of consolidated and affiliated centers. RDNT: RadNet is a national leader in outpatient diagnostic imaging, leveraging a large physical center network and proprietary AI technology to transform radiology workflows.
Side-by-side fundamentals
| Metric | LMRI | RDNT | Edge |
|---|---|---|---|
| Price as of 2026-10-22 close | $10.89 | $70.26 | |
| Market cap | $1.0B | $5.5B | |
| Net margin FY2025, SEC XBRL | n/a | -0.9% | |
| Operating margin FY2025, SEC XBRL | n/a | +3.0% | |
| ROE FY2025, SEC XBRL | n/a | -1.4% | |
| ROA FY2025, SEC XBRL | n/a | -0.5% | |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 1.36 | 1.22 | RDNT lower |
| Revenue growth (YoY) FY2025, SEC XBRL | n/a | +11.5% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +12.6% | |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 1.82 | 1.10 | |
| 1-year return as of 2026-10-22 close | n/a | -12.9% |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.